跳至主要内容
临床试验/NL-OMON51755
NL-OMON51755已完成不适用

Clinical investigation of the safety of the MediSieve Magnetic Haemofiltration System in healthy volunteers. - MediSieve FMS study

MediSieve Limited0 个研究点目标入组 6 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Written informed consent
  • - Age >= 18 and <= 50 years
  • - Healthy (as determined b y medical history, physical examination, vital
  • signs, 12-lead electrocardiogram (ECG) and routine clinical laboratory
  • parameters)

排除标准

  • - Chronic medication use (except contraception)
  • - Pregnant or lactating females
  • - Hypersensitivity to any of the (non)investigational products or their
  • - History of:
  • - Aneurysmal or hemorrhagic disease
  • - Heparin-induced thrombocytopenia
  • - Renal or hepatic impairment
  • - Peptic or gastric ulcer disease
  • - Family history of haemorrhagic or thromboembolic disorders (<50 years of age)

研究者

发起方
MediSieve Limited

相似试验

Clinical investigation of the safety of the... | 临床试验